Navigation Links
Cardo Medical Announces FDA Clearance of the Align 360 Total Knee System
Date:10/30/2008

LOS ANGELES, Oct. 30 /PRNewswire/ -- Cardo Medical, a company engaged in the development of orthopedic medical devices, announces the FDA 510k clearance of its Align 360 Total Knee System. The Align 360 Total Knee System is planned for commercial release during the second quarter of 2009. Cardo Medical's innovative Total Knee System is the flagship product within its Align 360 platform which has already received FDA clearance for its Uni-Compartmental and Patello-Femoral systems. All three systems feature a unique modular approach and common instrumentation system with a revolutionary concept designed to deliver simplified, reproducible surgical outcomes. Cardo Medical's Uni-Compartmental System, which was the first product release within the Align 360 platform, has been used successfully in over 500 surgeries to date.

John Kuczynski, Cardo Medical's Vice-President of Research and Development, commented, "The Align 360 Total Knee System is truly an advanced knee platform. Its femoral component features a funnel-shaped patella track that accommodates the quadriceps angle anatomy for both male and female patients, without the need for gender specific components which provides a tremendous inventory savings for all operating rooms. In addition, the anterior geometry of the femoral component has been designed to reduce antero-medial overhang of the femoral component, which has been clinically proven to be a cause of post-operative knee pain."

Dr. Andrew Brooks, Chairman and Chief Executive Officer of Cardo Medical stated, "We are pleased to have achieved this regulatory milestone and are excited to have rounded out our Align 360 platform. Our Total Knee System builds upon our Uni-compartmental and Patella-Femoral systems and is designed as a high performance treatment for tri-compartmental arthritis with choice of either a cruciate sparing or posterior stabilizing device. We now have a unique and comprehensive knee system which allows the surgeon to
'/>"/>

SOURCE Cardo Medical
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. clickNsettle.com, Inc. and Cardo Medical, LLC Announce Merger Agreement
2. Guardian Provides National Access to In-Network Medical Benefits
3. American Medical Association Endorses CAQH CORE Effort to Standardize and Streamline Patient Administrative Data Exchange
4. Oaks Development Group Closes on 2.1 Acres for Medical Office Building in Palm Coast, FL
5. CPC Appoints Medical Product Service GmbH as Authorized European Representative for MedClose(TM) System
6. Cantel Medical Corp. to Present at the Oppenheimer & Co. 19th Annual Healthcare Conference
7. Lazarex Cancer Foundation Sponsors Community Colorectal Cancer Screening at Alta Bates Summit Medical Center
8. China Medical Technologies to Attend Credit Suisse Asian Healthcare Conference
9. ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call
10. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
11. China Sky One Medical, Inc. Acquires Drug to Treat Breast Lesions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...c. 4 , ,What: Humana ( h..., health benefits provider, is intro...es.com ), a senior-friendly dance pad, ...Tues., Dec. 8 at 1 p.m. The festive...en to the public, will feature Dancetown, ...
(Date:12/4/2009)...RNewswire/ -- PLUS Diagnostics announced today t...gy services with the launch of a national hematolo...e company,s expansion from a regional laboratory t...fering diagnostic services across a full range of ...d now hematology/oncology. ,, PLUS Diagnostics...
(Date:12/4/2009)...wswire/ -- The National Cancer Institute has award... Hutchinson Cancer Research Center to become the n...rvice Contact Center. ,, The move will create 6...ing the size of its current CIS workforce - once t... is scheduled for March 15, 2010. The Seattle CIS ...
(Date:12/4/2009)...s multi-language patient education leaflets suppor...ds for language access in healthcare organizations...cember 5, 2009 -- Lexi-Comp, Inc., a provider of c...ent education materials for healthcare institution...cation between the health care professional and th...
(Date:12/4/2009)...et herpes zoster virus, study finds , , ...e vaccinated against chicken pox may also have inc...uggest. , U.S. researchers looked at the health...a who were vaccinated with the varicella (chicken ...verage of 2.5 years after receiving the chicken po...
Breaking Medicine News(10 mins):Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 3Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2Health News:Lexi-Comp Focused on Improving Patient Communication in Healthcare Institutions Treating Diverse Patient Populations 2Health News:Lexi-Comp Focused on Improving Patient Communication in Healthcare Institutions Treating Diverse Patient Populations 3
.... 7 Large employers say they,are not ready to bai...ealth,insurance coverage in the United States, acc...tisan Employee Benefit Research Institute (EBRI). ...picture could shift quickly if one large employer ...
... vehicles that run on both conventional gasoline a...ap until more sustainable technology is developed,...e Inderscience publication International Journal o...ric vehicles. , Jean-Jacques Chanaron Research Di...
... Establish Norman E. Borlaug Hall of Laureates, D... announced a $1 million contingent donation to fun...rld Food Prize in Des Moines. The donation,will su...business Pioneer Hi-Bred., "The World Food Prize ...
...soles will also be introduced, AMHERST, Mass., Fe...les, has partnered with Merrell to incorporate its...tyles. By early 2008,Merrell will expand the numbe...ll introduce a new line of aftermarket insoles,to ...
...vailable From Pantek Technologies Corp. With Mass ...8, HERZLIYA, Israel, February 7 Dblur, the devel...ced the availability of a,stand-alone chip that in... to 3.2Mp. Samples are currently available from Pa...
...eria found in healthy women help to reduce the amo...ke it more difficult for the virus to spread, boos...day be tapped in the fight against HIV. , The fin...fort to learn more about how HIV survives and spre...
Other Medicine News:Health News:EBRI Policy Forum: Large Employers Continue to Offer Health Benefits 2Health News:The trouble with hybrids 2Health News:DuPont Pledges $1 Million to World Food Prize 2Health News:DuPont Pledges $1 Million to World Food Prize 3Health News:Merrell Updates Performance Line with the Launch of OrthoLite Insoles 2Health News:Dblur Announces the Availability of a Software Lens(TM) Enabled Chip 2Health News:Dblur Announces the Availability of a Software Lens(TM) Enabled Chip 3Health News:'Good bacteria' in women give clues for slowing HIV transmission 2Health News:'Good bacteria' in women give clues for slowing HIV transmission 3
(Date:12/3/2009)...wire/ -- ParagonRx, a Delaware-based company speci...mal medication use, will host a free webinar on We...MS - Risk Evaluation Mitigation Strategy - program...nt. Dr. Gary Slatko, chief medical officer of Par...rograms, will lead the one-hour program beginning ...
(Date:12/3/2009)...stCall/ -- Cardium Therapeutics (NYSE Amex: CXM )... Tissue Repair Company, submitted a 510(k) premark... Administration (FDA) seeking marketing clearance ... positive data from the Company,s recently complet...sion with the FDA covers Excellagen XL(TM) and Ex...
(Date:12/3/2009)...RNewswire-FirstCall/ -- Each year, hundreds of und...(U.S.) and Europe participate in the Amgen Scholar...nder renowned faculty members at the world,s leadi...present and future - will have exclusive access to...scholars.com . ,, "The new Web site is designe...
Breaking Medicine Technology:Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 2New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 3Medco to Present at November 2009 Investor Conferences 5692 1Medco to Present at November 2009 Investor Conferences 5692 2LA BioMed researcher to be honored 60089 1LA BioMed researcher to be honored 60089 2Science at the petascale 3A Roadrunner results unveiled 60085 1Science at the petascale 3A Roadrunner results unveiled 60085 2Science at the petascale 3A Roadrunner results unveiled 60085 3
...Mar 22, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB...f the analysis of results from the Company,s phase.... The clinical,direction for AEOL 10150 is current...ts for an efficacy study as a protector of healthy...head and neck,cancer and Amyotrophic Lateral Scler...
...--Mar 22, 2007 - FzioMed,Inc. announced today tha...thetic dermal fillers is being presented at the,An...arlo March,22-24, 2007., In 2006, FzioMed launched...n-permanent, synthetic filler created from the,com...s a completely,new class of filler for the correct...
Other Medicine Technology:Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 2Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 3Aeolus Pharmaceuticals Announces Successful Completion of Multiple,Dose Safety Study of AEOL 10150 4Laresse Dermal Filler Research Presented at Anti-Aging World,Congress 2
RABIT
Albumin Reagent Set
AST (SGOT)
AST (GOT) + Starter Reagent
Medicine Products: